ACTIMED makes investments in the sector of high performance materials related to health. The company is at the origin of the strategic merger between Medical Technologie Diffusion, France and Westlake Plastics, USA. The MTD / Westlake Plastics project “MTD”, now renamed “Westlake Plastics Europe”, has since 1989 been a leader in the European distribution of medical grade polymers mainly used by the orthopedic industry. In the USA, Westlake Plastics transforms polymer granules into semi-finished products by extrusion or compression. Westlake Plastics Europe has in-house high-performance machining capacity (Active Medical) offering healthcare players the possibility of sourcing raw material or machined parts. The extruded or compressed polymers are machined into instrumentation parts to aid in the placement of implants or into implantable parts (friction surface for the hip, knee, shoulder, ankle). Westlake Plastics Europe has in-house high-performance machining capacity (Active Medical) offering healthcare players the possibility of sourcing raw material or machined parts. In the USA, Westlake Plastics transforms polymer granules into semi-finished products by extrusion or compression. Now united under a common shareholding structure, the two entities form a group which achieves a consolidated turnover of $ 21 million and employs more than 120 people in the United States and in France. www.westlakeplastics.com www.am-mtd.com Shareholding Actimed is a family group, managed by family members and supported by Turenne Santé and Nord Capital Partenaires, minority shareholders alongside them. The support of these two institutional players aims to strengthen the group's financial resources while providing them with strategic expertise. www.turenne-sante.com www.nord-cp.com ACTIMED © 2013 - Contact